Connect your AI

Eli Lilly LLY Total Current Liabilities

Total Current Liabilities at other companies

PfizerPFE

$34.35B-5.8%

AmgenAMGN

$24.96B+8.5%

Cardinal HealthCAH

$41.99B+14.5%

MannkindMNKD

$134.56M+16.1%

Oruka Therapeutics, Inc.ORKA

$16.63M+41.9%

McKessonMCK

$67.02B+8.8%

Other financials

Income statement

Revenue$19.8B+55.5%

Gross profit$16.2B+54.4%

Net income$7.4B+168%

EPS (diluted)$8.26+170%

Balance sheet

Cash & equivalents$5.3B+70.8%

Total debt$43.4B+12.6%

Total equity$31.2B+97.9%

Total assets$116.58B+30.4%

Cash flow

Operating cash flow$5.3B+220%

CapEx$2.3B+54.0%

Free cash flow$3.0B+1,828%

Valuation

Market cap$1.09T+56.4%

Enterprise value$1.12T+53.8%

P/E42.9×-7.3×

P/S15×+2.0×

Profitability

Gross margin82.8%+1.1pp

Net margin35%+12.3pp

FCF margin16.4%+8.7pp

Returns & leverage

Return on equity107.6%+29.9pp

Debt / equity1.4×-1.1×

Current ratio1.5×+0.1×

Where this comes from

Reported directly by Eli Lilly in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.

The official record: Eli Lilly’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Eli Lilly's total current liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Eli Lilly's total current liabilities?: Eli Lilly (LLY) reported total current liabilities of $36.63B in Q1 2026.
How has Eli Lilly's total current liabilities changed year-over-year?: Eli Lilly's total current liabilities increased by 21.8% year-over-year, from $30.07B to $36.63B.
What is the long-term trend for Eli Lilly's total current liabilities?: Over 5 years (2020 to 2025), Eli Lilly's total current liabilities has grown at a 23.1% compound annual growth rate (CAGR), from $12.48B to $35.23B.
What does total current liabilities mean?: The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.